Wells Fargo & Company Cuts Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $20.00
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price decreased by Wells Fargo & Company from $22.00 to $20.00 in a research note issued to investors on Thursday,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the medical device company’s stock. Other equities research analysts have also recently issued […]
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price decreased by Wells Fargo & Company from $22.00 to $20.00 in a research note issued to investors on Thursday,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the medical device company’s stock. Other equities research analysts have also recently issued […]
